4.6 Review

Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome

期刊

TRENDS IN MOLECULAR MEDICINE
卷 27, 期 9, 页码 895-906

出版社

CELL PRESS
DOI: 10.1016/j.molmed.2021.06.002

关键词

-

资金

  1. US Public Health Service grant [5U54AI138370]

向作者/读者索取更多资源

SARS-CoV-2 infection can lead to chronic and acute diseases, with postacute sequelae including potential organ damage and symptoms, as well as a post-COVID19 syndrome called 'long COVID' resembling ME/CFS symptoms.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause chronic and acute disease. Postacute sequelae of SARS-CoV-2 infection (PASC) include injury to the lungs, heart, kidneys, and brain that may produce a variety of symptoms. PASC also includes a post-coronavirus disease 2019 (COVID-19) syndrome ('long COVID') with features that can follow other acute infectious diseases and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Here we summarize what is known about the pathogenesis of ME/CFS and of 'acute' COVID-19, and we speculate that the pathogenesis of post-COVID19 syndrome in some people may be similar to that of ME/CFS. We propose molecular mechanisms that might explain the fatigue and related symptoms in both illnesses, and we suggest a research agenda for both ME/CFS and post- COVID-19 syndrome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据